documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

16 rows where docket_id = "FDA-2002-N-0279" and posted_year = 2011 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: last_modified, posted_date (date), last_modified (date)

posted_year 1

  • 2011 · 16 ✖

document_type 1

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2002-N-0279-0027 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 20 - [Reference (Drug Expenditure Tables)] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T22:02:41Z   0 0 090000648049e6cc
FDA-2002-N-0279-0016 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 4 - [Reference (FDA to Lord, Bissell & Brook on Behalf of Apotex, Inc. Citizen Petition)] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:06Z   0 0 090000648049e6c6
FDA-2002-N-0279-0024 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 14 - [Reference (Congressional Budget Office "How Increased Competition from Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry" (July 1998))] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:20Z   0 0 090000648049e6c9
FDA-2002-N-0279-0013 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 1 - [Reference "FTC Citizen Petiton"] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:06Z   0 0 090000648049e6bc
FDA-2002-N-0279-0017 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 5 - [Reference (Guidance for Industry "Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients")] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:06Z   0 0 090000648049e6c7
FDA-2002-N-0279-0019 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 7 - [Reference Andrx Pharmaceuticals, Inc. v. Biovail Corporation International and Tommy Thompson, Secretary DHHS] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:07Z   0 0 090000648049e6cd
FDA-2002-N-0279-0022 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 10 - [Reference "The Patent Term Restoration Act of 1983"] (page 48, 56 and 57 Lewis A. Engman Comment)] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:20Z   0 0 090000648049e6c3
FDA-2002-N-0279-0020 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 8 - [Reference "Congressional House" (Page H 6916 thru H 6921 (9/13/1982))] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:19Z   0 0 090000648049e6bf
FDA-2002-N-0279-0012 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Reference Listing - [Tab 1 thru 19 Reference Title List] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:13:53Z   0 0 090000648049e6bd
FDA-2002-N-0279-0026 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 19 - [Reference "National Health Care Expenditures Projections: 2001-2011" (Centers for Medicare & Medicaid Services - Office of the Actuary)] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T22:01:17Z   0 0 090000648049e6cb
FDA-2002-N-0279-0021 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 9 - [Reference "Congressional House" (Page H 6922 thru H 6924 (9/13/1982))] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:20Z   0 0 090000648049e6c1
FDA-2002-N-0279-0014 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 2 - [Reference "Generic Drug Entry Prior to Patent Expiration" (An FTC Study (July 2002))] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:57:55Z   0 0 090000648049e6c0
FDA-2002-N-0279-0015 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 3 - [Reference (FDA to Biovail Laboratories Inc.)] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:06Z   0 0 090000648049e6c4
FDA-2002-N-0279-0018 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 6 - [Reference (FDA to Beers, Korn, Arnold & Porter, McNichol, Scheineson, Frisch, Smith (Petiton Denial))] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:07Z   0 0 090000648049e6c8
FDA-2002-N-0279-0025 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 16 - [Reference "The Pediatric Exclusivity Provision - January 2001 Status Report to Congress" [DHHS/FDA]] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:49:03Z   0 0 090000648049e6ca
FDA-2002-N-0279-0023 FDA Applications for FDA Approval to Market a New Drug FDA-2002-N-0279 Tab 11 - [Reference (Mr. Kastenmeier Report from Judiciary Committee)] - Background Material Supporting & Related Material Reference (external attachments) 2011-11-17T05:00:00Z 2011 11     2011-11-17T21:14:20Z   0 0 090000648049e6c5

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;